These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18070709)

  • 1. Pathophysiology of myeloma bone disease.
    Esteve FR; Roodman GD
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):613-24. PubMed ID: 18070709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of myeloma bone disease.
    Roodman GD
    J Cell Biochem; 2010 Feb; 109(2):283-91. PubMed ID: 20014067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Myeloma and Bone: The Fatal Interaction.
    Marino S; Roodman GD
    Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29229668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of myeloma bone disease.
    Roodman GD
    Leukemia; 2009 Mar; 23(3):435-41. PubMed ID: 19039321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma bone disease: Pathophysiology and management.
    Silbermann R; Roodman GD
    J Bone Oncol; 2013 Jun; 2(2):59-69. PubMed ID: 26909272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New agents in the Treatment of Myeloma Bone Disease.
    Ring ES; Lawson MA; Snowden JA; Jolley I; Chantry AD
    Calcif Tissue Int; 2018 Feb; 102(2):196-209. PubMed ID: 29098361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N; Colla S; Rizzoli V
    Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of bone destruction in multiple myeloma.
    Terpos E; Christoulas D; Gavriatopoulou M; Dimopoulos MA
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28940410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of the bone disease of multiple myeloma.
    Edwards CM; Zhuang J; Mundy GR
    Bone; 2008 Jun; 42(6):1007-13. PubMed ID: 18406675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional three-dimensional microphysiological human model of myeloma bone disease.
    Visconti RJ; Kolaja K; Cottrell JA
    J Bone Miner Res; 2021 Oct; 36(10):1914-1930. PubMed ID: 34173283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone disease in multiple myeloma.
    Drake MT
    Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):28-32. PubMed ID: 20128326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New potential targets for treating myeloma bone disease.
    Roodman GD
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6270s-6273s. PubMed ID: 17062712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and treatment of myeloma related bone disease.
    Terpos E; Christoulas D; Gavriatopoulou M
    Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypercalcemia in myeloma].
    Abe M
    Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatment approaches for myeloma-related bone disease.
    Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
    Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Evidence-Based Approach to Myeloma Bone Disease.
    Bingham N; Reale A; Spencer A
    Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.